Volition reports FY earnings ahead of cancer drug launch – STOCKTRKR

13 March 2017: Volition reports its full year earnings as it readies itself to launch its blood test for bowel cancer across Europe. IG’s Jeremy Naylor talks to the CEO Cameron Reynolds.

Trade Forex, Commodities, Stocks and more, trade CFDs on the Plus 500 CFD trading platform! *CFD Service. 80.6% lose money - Register a real money account here and get trading right away.

Related Posts:

Shares ceo talk Commentary company IG markets Shares stocks UK shares video

Weekly Technical Outlook: 15/04/2024 – GBPUSD, USDJPY, AUDUSD

Weekly Forex Outlook: 12/04/2024 – More inflation data on the way as rate cut bets in disarray

Weekly Technical Outlook: 08/04/2024 – USDJPY, EURGBP, USDCAD

Weekly Forex Outlook: 05/04/2024 – ECB decision and US inflation to fuel FX volatility